- ►clinicaltherapeutics.com [PDF] A Vinik - Clinical therapeutics, 2007 - Elsevier Methods: Relevant English-language articles published from 1996 to 2006 were
identified through searches of the National Center for Biotechnology PubMed
database. Search terms included insulin, insulin therapy, type 2 diabetes, ... Cited by 13 - Related articles - All 4 versions
- ►nih.gov I Hartman - Clinical medicine & research, 2008 - Marshfield Clinic A growing body of medical research has demonstrated that intensive control of
serum glucose levels can minimize the development of diabetes-related
complications. Success with insulin management ultimately depends on how ... Cited by 10 - Related articles - All 8 versions
G Dailey - Clinical therapeutics, 2007 - Elsevier Results: Eight clinical studies to date have reported that IDPI consistently
improved glycemic control, whether used in combination with longer-acting SC
insulin regimens in patients with type 1 or type 2 DM or to supplement or ... Cited by 6 - Related articles - All 3 versions
C Bradley, CJB Gilbride - Diabetes Obes Metab, 2008 - eprints.rhul.ac.uk Page 1. 1 This is not the definitive version. The definitive version is in press
and can be found at the following reference: Bradley C and Gilbride CJB. ... Cited by 4 - Related articles - All 3 versions
MM Funnell - Insulin, 2008 - Elsevier Results: Although patient-identified concerns regarding insulin use represent
some aspects of quality of life, study results have been mixed. However, 2 large
studies examining the use of insulin glargine and its effects on quality of ... Cited by 3 - Related articles
KL Edwards, C Alvarez, BK Irons, J Fields - Pharmacotherapy, 2008 - PPI Patients with type 2 diabetes mellitus often begin treatment by taking oral
agents, usually metformin or a sulfonylurea, and then progress to the
combination of these two agents. Most patients often require three or more ... Cited by 2 - Related articles - BL Direct - All 3 versions
MA Elrishi, J Jarvis, K Khunti, MJ Davies - Expert Opin. Drug Metab. Toxicol., 2008 - informahealthcare.com Background: Insulin glargine (Lantus ® ) was the first recombinant-DNA
long-acting insulin analogue to be licensed for use in the treatment of diabetes
mellitus. Objective: This review considers the use of insulin glargine in ... Cited by 1 - Related articles - All 7 versions
MJP van Avendonk, G Rutten - Diabetes, Obesity and Metabolism, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 2 - Related articles - All 3 versions
R Clissold, S Clissold - Core Evidence, 2007 - dovepress.com Effective glycemic control in type 2 diabetes Clear IG was at least as effective
as NPH insulin, other insulin regimens, and rosiglitazone or pioglitazone Lower
incidence of hypoglycemia in type 2 diabetes Clear Significantly less ... Cited by 1 - Related articles - View as HTML - BL Direct - All 3 versions
